Doxepin Pharmacodynamics: Indication or Adverse Effect?
Med Ed 101
FEBRUARY 21, 2021
Doxepin is a tricyclic antidepressant first approved for the treatment of depression in 1969 by the FDA. Tricyclic antidepressants are famous for their anticholinergic adverse effects including sedation and have been replaced by better-tolerated medications as first-line agents for depression. appeared first on Med Ed 101.
Let's personalize your content